Literature DB >> 34596684

Response to letter to the editor by Moudgil-Joshi and Kaliaperumal.

David N Louis1, Ian A Cree2.   

Abstract

Entities:  

Year:  2021        PMID： 34596684      PMCID： PMC8643463          DOI： 10.1093/neuonc/noab215

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  5 in total

1.  A Global View on the Availability of Methods and Information in the Neuropathological Diagnostics of CNS Tumors: Results of an International Survey Among Neuropathological Units.

Authors:  Felipe Andreiuolo; Aurélien Mazeraud; Fabrice Chrétien; Torsten Pietsch
Journal:  Brain Pathol       Date:  2016-07       Impact factor: 6.508

2.  Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors.

Authors:  Yukihiko Sonoda; Hideaki Yokoo; Shinya Tanaka; Manabu Kinoshita; Mitsutoshi Nakada; Hiroshi Nishihara
Journal:  Brain Tumor Pathol       Date:  2019-03-07       Impact factor: 3.298

3.  ISNO consensus guidelines for practical adaptation of the WHO 2016 classification of adult diffuse gliomas.

Authors:  Vani Santosh; Palavalasa Sravya; Tejpal Gupta; Dattatraya Muzumdar; Geeta Chacko; Vaishali Suri; Sridhar Epari; Anandh Balasubramaniam; Bishan Dass Radotra; Sandip Chatterjee; Chitra Sarkar; Rakesh Jalali
Journal:  Neurol India       Date:  2019 Jan-Feb       Impact factor: 2.117

Review 4.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Pieter Wesseling; Daniel J Brat; Ian A Cree; Dominique Figarella-Branger; Cynthia Hawkins; H K Ng; Stefan M Pfister; Guido Reifenberger; Riccardo Soffietti; Andreas von Deimling; David W Ellison
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

5.  Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community.

Authors:  Kenneth Aldape; Romina Nejad; David N Louis; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300
  5 in total
  8 in total

Review 1.  Roles of circular RNAs in regulating the development of glioma.

Authors:  Jianing Fan; Yangyang Wang; Xiao Liang; Fanlin Zhou; Shijie Li; Xiaoju Li; Yu Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-01       Impact factor: 4.553

2.  Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma.

Authors:  Ryo Kurokawa; Mariko Kurokawa; Akira Baba; Yoshiaki Ota; John Kim; Aristides Capizzano; Ashok Srinivasan; Toshio Moritani
Journal:  Eur Radiol       Date:  2022-01-13       Impact factor: 5.315

Review 3.  Prognostic significance of TERT promoter mutations in adult-type diffuse gliomas.

Authors:  Hideyuki Arita; Koichi Ichimura
Journal:  Brain Tumor Pathol       Date:  2022-01-31       Impact factor: 3.298

4.  Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation.

Authors:  Yukitomo Ishi; Shigeru Yamaguchi; Michinari Okamoto; Ryosuke Sawaya; Shogo Endo; Hiroaki Motegi; Shunsuke Terasaka; Zen-Ichi Tanei; Kanako C Hatanaka; Shinya Tanaka; Miki Fujimura
Journal:  Brain Tumor Pathol       Date:  2022-04-01       Impact factor: 3.298

5.  The prognostic role of the immunohistochemical expression of S100 in meningiomas.

Authors:  Felix Behling; Christina Fodi; Marco Skardelly; Frank Paulsen; Ghazaleh Tabatabai; Jürgen Honegger; Marcos Tatagiba; Jens Schittenhelm
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-15       Impact factor: 4.322

6.  Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics.

Authors:  Paulina Śledzińska; Marek Bebyn; Ewelina Szczerba; Jacek Furtak; Maciej Harat; Natalia Olszewska; Katarzyna Kamińska; Janusz Kowalewski; Marzena A Lewandowska
Journal:  Mol Diagn Ther       Date:  2022-09-02       Impact factor: 4.476

7.  Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1.

Authors:  Patrick J Cimino; Courtney Ketchum; Rust Turakulov; Omkar Singh; Zied Abdullaev; Caterina Giannini; Peter Pytel; Giselle Yvette Lopez; Howard Colman; MacLean P Nasrallah; Mariarita Santi; Igor Lima Fernandes; Jeff Nirschl; Sonika Dahiya; Stewart Neill; David Solomon; Eilis Perez; David Capper; Haresh Mani; Dario Caccamo; Matthew Ball; Michael Badruddoja; Rati Chkheidze; Sandra Camelo-Piragua; Joseph Fullmer; Sanda Alexandrescu; Gabrielle Yeaney; Charles Eberhart; Maria Martinez-Lage; Jie Chen; Leor Zach; B K Kleinschmidt-DeMasters; Marco Hefti; Maria-Beatriz Lopes; Nicholas Nuechterlein; Craig Horbinski; Fausto J Rodriguez; Martha Quezado; Drew Pratt; Kenneth Aldape
Journal:  Acta Neuropathol       Date:  2022-10-22       Impact factor: 15.887

8.  MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region.

Authors:  Nauman Malik; Benjamin Geraghty; Arjun Sahgal; Gregory J Czarnota; Archya Dasgupta; Pejman Jabehdar Maralani; Michael Sandhu; Jay Detsky; Chia-Lin Tseng; Hany Soliman; Sten Myrehaug; Zain Husain; James Perry; Angus Lau
Journal:  J Neurooncol       Date:  2021-10-25       Impact factor: 4.130
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.